These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22629)

  • 41. Effect of serotonin uptake blocking agents on the flexor reflex of hind limb of the spinal rat.
    Palider W; Rawlów A
    Pol J Pharmacol Pharm; 1977; 29(4):367-76. PubMed ID: 905204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors modulating brain serotonin turnover.
    Diaz PM; Ngai SH; Costa E
    Adv Pharmacol (1962); 1968; 6(Pt B):75-92. PubMed ID: 5658336
    [No Abstract]   [Full Text] [Related]  

  • 43. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 44. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat.
    Samanin R; Bendotti C; Candelaresi G; Garattini S
    Life Sci; 1977 Nov; 21(9):1259-66. PubMed ID: 270605
    [No Abstract]   [Full Text] [Related]  

  • 45. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB; West WB; Buggy J
    Neurosci Biobehav Rev; 2004 Jan; 27(8):693-701. PubMed ID: 15019419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal 5-hydroxytryptamine receptors outside the central nervous system.
    Wallis D
    Life Sci; 1981 Dec; 29(23):2345-55. PubMed ID: 7033702
    [No Abstract]   [Full Text] [Related]  

  • 49. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible involvement of brain serotonin in apomorphine-induced hypothermia.
    Grabowska M; Michaluk J; Antkiewicz L
    Eur J Pharmacol; 1973 Jul; 23(1):82-9. PubMed ID: 4270157
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotoninergic receptors during ontogenesis in the rat.
    Bourgoin S; Artaud F; Enjalbert A; Héry F; Glowinski J; Hamon M
    J Pharmacol Exp Ther; 1977 Sep; 202(3):519-31. PubMed ID: 894519
    [No Abstract]   [Full Text] [Related]  

  • 53. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.
    Laubscher A; Pletscher A; Noll H
    J Pharmacol Exp Ther; 1981 Feb; 216(2):385-9. PubMed ID: 6109775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Block by LSD of the increase in brain serotonin turnover induced by elevated ambient temperature.
    Aghajanian GK; Weiss BL
    Nature; 1968 Nov; 220(5169):795-6. PubMed ID: 5698754
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment.
    Dawbarn D; Long SK; Pycock CJ
    Br J Pharmacol; 1981 May; 73(1):149-56. PubMed ID: 6116511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.